Jane Street
APGN

Jane Street’s Apexigen, Inc. Common Stock APGN Stock Holding History

Jane Street’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,799
Closed -$12.1K – 10320
2022
Q4 		$12.1K Sell
17,799
-16,622
-48% -$32.4K ﹤0.01% 8729
2022
Q3 		$93K Sell
34,421
-42,929
-55% -$349K ﹤0.01% 8689
2022
Q2 		$786K Buy
77,350
+1,549
+2% +$15.7K ﹤0.01% 5927
2022
Q1 		$764K Sell
75,801
-612
-0.8% -$6.14K ﹤0.01% 6690
2021
Q4 		$765K Buy
76,413
+760
+1% +$7.57K ﹤0.01% 6448
2021
Q3 		$753K Buy
75,653
+1,324
+2% +$13.1K ﹤0.01% 6495
2021
Q2 		$738K Buy
74,329
+16,359
+28% +$162K ﹤0.01% 6484
2021
Q1 		$570K Buy
+57,970
New +$580K ﹤0.01% 6565

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street's APGN Position: Q1 2023 in Review

Jane Street sold out of Apexigen, Inc. Common Stock (APGN) in Q1 2023, closing a stake of 17,799 shares — an estimated $12.1K sold.

Jane Street first reported a position in APGN in Q1 2021 and held it in 8 quarters. The position peaked at $786K in Q2 2022. 20 funds tracked by Wall St. Rank hold APGN as of Q1 2023.

  • Jane Street reported no remaining Apexigen, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 17,799 Apexigen, Inc. Common Stock shares in Q1 2023, an estimated $12.1K.
  • Jane Street first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Jane Street's Apexigen, Inc. Common Stock position peaked at $786K in Q2 2022.
  • 20 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.